Immunoglobulin light chain (IgLC) is a component of antibodies, but its free form is observed in the circulation, which originates from 10 to 40% excess synthesis over heavy chain in B cells. Complete antibodies function as a defined tetramer structure unit, H2L2; thus, separation of heavy and light chains results in considerable or complete loss of antigen-binding ability. Free IgLC has been considered as an inconsequential spillover during antibody assembly because, unlike heavy chain, neither effector functions such as complement activation nor specific-receptor binding has been identified in IgLCs. Free IgLC in sera and cerebrospinal fluids increases in inflammatory diseases such as autoimmune diseases and infections, presumably as a result of B-cell activation. This may be just a concomitant event during elevated disease activity, but recent findings suggest that free IgLC is involved in a wide range of immunological phenomena as a signaling effector or an anti-inflammatory molecule. These effects are likely to be intrinsic to IgLC. In this review, we attempt to give a comprehensive view about the biological roles of free IgLC together with the gene expression, secretion, antigen-binding ability, and its metabolic characteristics.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cca.2011.03.007DOI Listing

Publication Analysis

Top Keywords

free iglc
16
immunoglobulin light
8
light chain
8
heavy chain
8
antigen-binding ability
8
free
6
iglc
6
free immunoglobulin
4
chain
4
chain biology
4

Similar Publications

Introduction: Exposure to secondhand smoke (SHS) among women is prevalent in China which increases their risk of developing a wide range of diseases and can affect their susceptibility to adverse reproductive health effects. This study aims to examine the association between SHS exposure among women and the adoption and implementation of tobacco control measures on campus in China.

Aims And Methods: 7469 female college students who have never smoked were recruited from 50 universities across China using a multistage sampling technique.

View Article and Find Full Text PDF

Functional analysis of tumor-derived immunoglobulin lambda and its interacting proteins in cervical cancer.

BMC Cancer

October 2023

Fujian Provincial Institutes of Brain Disorders and Brain Sciences, The First Affiliated Hospital, Fujian Medical University, Fuzhou, China.

Background: Immunoglobulin lambda (Igλ) has been reported to be expressed in many normal and tumor tissues and cells. However, the function and clinical significance of tumor-derived Igλ remain unclear.

Methods: The differential expressions of Immunoglobulin Lambda Constants (IGLCs) in cervical squamous cell carcinoma and endocervical adenocarcinoma (CESC) were examined with The Cancer Genome Atlas (TCGA), Genotype-Tissue Expression (GTEx), and Human Protein Atlas (HPA) databases.

View Article and Find Full Text PDF

Integrated-gut-liver-on-a-chip platform as an in vitro human model of non-alcoholic fatty liver disease.

Commun Biol

March 2023

Institute for Integrated Cell-Material Sciences, Kyoto University, Yoshida-Ushinomiya-cho, Sakyo-ku, Kyoto, 606-8501, Japan.

Article Synopsis
  • Non-alcoholic fatty liver disease (NAFLD) affects many people, but effective treatments are lacking due to limitations in current research methods.
  • The study introduces an integrated-gut-liver-on-a-chip (iGLC) system that simulates human gut-liver interactions by co-culturing gut and liver cell lines in a microfluidic environment, allowing for observation of NAFLD development.
  • Results show that gut-liver co-cultured cells can protect against fat-induced cell death, while providing insights into lipid accumulation and gene expression changes linked to cellular stress, suggesting the iGLC platform could replace animal testing for studying NAFLD.
View Article and Find Full Text PDF

FipB, an essential virulence factor in the highly virulent Schu S4 strain of F. tularensis subsp. tularensis, shares sequence similarity with Disulfide Bond formation (Dsb) proteins, which can have oxidoreductase, isomerase, or chaperone activity.

View Article and Find Full Text PDF

A stable live bacterial vaccine.

Eur J Pharm Biopharm

June 2016

Department of Pharmaceutical Sciences, College of Pharmacy, University of New Mexico, Albuquerque, NM, USA. Electronic address:

Formulating vaccines into a dry form enhances its thermal stability. This is critical to prevent administering damaged and ineffective vaccines, and to reduce its final cost. A number of vaccines in the market as well as those being evaluated in the clinical setting are in a dry solid state; yet none of these vaccines have achieved long-term stability at high temperatures.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!